Company Filing History:
Years Active: 1997-2007
Title: Carina P Tan: Innovator in Molecular Pharmacology
Introduction
Carina P Tan, an accomplished inventor based in Metuchen, NJ, has made significant contributions in the field of molecular pharmacology. With a portfolio of 10 patents to her name, she stands out for her research on receptors that play vital roles in various physiological functions. Her innovative approach and dedication to science have led to noteworthy advancements in understanding receptor biology.
Latest Patents
Among her latest patents, Tan has focused on the Rhesus monkey, dog, and ferret melanin-concentrating hormone type 2 receptor (MCH-2R). This groundbreaking work identifies the presence of MCH-2R in these animals, emphasizing its distinction from the MCH-1R. The patent includes descriptions of MCH-2R polypeptide and nucleic acid sequences, highlighting potential applications in medical research and therapeutic development.
Another notable patent involves the cloning and identification of the motilin receptor. This receptor has been isolated and cloned, revealing two splice variants and providing nucleic acid sequences for further study. The identification of this cloned receptor enables tailored screening of compounds that could bind to the receptor, which may have significant implications for treating gastric motility disorders.
Career Highlights
Carina P Tan's career includes meaningful engagements with leading biopharmaceutical companies such as Merck & Company, Inc. Her expertise has always been instrumental in integrating novel scientific approaches into practical solutions. Her work demonstrates a commitment to enhancing our understanding of complex molecular mechanisms, benefiting multiple avenues within medical research.
Collaborations
Throughout her career, Tan has collaborated with notable professionals in the field, including Margaret A Cascieri and Douglas J MacNeil. These collaborations have sparked innovative ideas and fueled the success of her projects, leading to advancements that contribute to the scientific community.
Conclusion
Carina P Tan exemplifies the spirit of innovation through her extensive research and impressive patent portfolio. Her contributions to the field of molecular pharmacology will continue to inspire future developments and research, solidifying her position as a leading inventor and scientist in the industry. Her work not only enhances our understanding of receptor biology but also opens new pathways for therapeutic interventions in various medical conditions.